Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Haematology & thrombosisPRM 4618
Dosage formHard-gelatin capsules
Oral

1, 2-Dimethyl-3-Hydroxypyrid-4-one 250 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron chelator
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4619
Dosage formHard-gelatin capsules
Oral

1, 2-Dimethyl-3-Hydroxypyrid-4-one 500 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron chelator
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 5178
Dosage formSyrup
Oral

Absolute Alcohol 5% v/v, Biotin 300 mcg, Chromium 25 mcg, Copper 0.45 mg, Elemental Iodine 75 mcg, Elemental Zinc 7.5 mg, Iron 18 mg, L-Lysine MonoHcl 50 mg, Manganese 1.0 mg, Methylcobalamin 500 mcg, Niacinamide 45 mg, Selenium 40 mcg, Vitamin B6 1.5 mg / 15 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Iron replacement / haematinic + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2599
Dosage formTablets
Oral

Acetyl Salicylic Acid 100 mg, Calcium Carbonate 30 mg, Citric Acid 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Salicylate analgesic / antiplatelet + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4632
Dosage formHard-gelatin capsules
Oral

Adenosyl Cobalamin 15 mcg, Carbonyl Iron 62 mg, Folic Acid 1500 ng, Zinc Oxide 25 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2620
Dosage formTablets
Oral

Adenosylcobalamin 15 mcg, Ferrous Ascorbate 100 mg, Folic Acid 1.5 mg, Zinc 22.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 0077
Dosage formTablets
Oral

Adenosylcobalamin 15 mcg, Ferrous Ascorbate 100 mg, Folic Acid 1.5 mg, Zinc Sulphate 22.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

FDC composition listed in CDSCO approval records

CDSCO filing reference · page 48
Haematology & thrombosisPRM 5180
Dosage formSyrup
Oral

Adenosylcobalamin 50 mcg, Folic Acid 1.5 mg, Iron 33 mg / 10 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2155
Dosage formHard-gelatin capsules
Oral

Adenosylcobalamin 500 mcg, Carbonyl Iron 100 mg, Folic Acid 1.5 mg, Zinc Sulphate 22.2 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 459
Haematology & thrombosisPRM 4633
Dosage formHard-gelatin capsules
Oral

Adenosylcobalamin 500 mcg, Carbonyl Iron 100 mg, Folic Acid 1.5 mg, Zinc Sulphate Monohydrate 22.2 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4634
Dosage formHard-gelatin capsules
Oral

Adenosylcobalamin 500 mcg, Elemental Iron 100 mg, Folic Acid 1.5 mg, Methylcobalamin 750 mcg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2623
Dosage formTablets
Oral

Adenosylcobalamin 500 mcg, Folic Acid 500 mcg, Iron 100 mg, Zinc 27.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2786
Dosage formTablets
Oral

Apixaban 2.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Direct factor Xa inhibitor
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2787
Dosage formTablets
Oral

Apixaban 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Direct factor Xa inhibitor
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4692
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 100 mg, Cyanocobalamin 15 mcg, Ferrous Fumarate 100 mg, Folic Acid 1.5 mg, Zinc 50 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4698
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 150 mg, Cyanocobalamin 15 mcg, Folic Acid 1.5 mg, Iron 112 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4700
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 300 mg, Iron 50 mg, Sodium Bicarbonate 84 mg, Talcum 12 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4701
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 40 mg, Cyanocobalamin (Vitamin B12) 2.5 mcg, Ferrous Fumarate 150 mg, Folic Acid 0.5 mg, Glycine 10 mg, L-Histidine Hcl Monohydrate 4 mg, L-Lysine Hcl 25 mg, Pyridoxine Hcl (Vitamin B6) 1.5 mg, Riboflavin (Vitamin B2) 3 mg, Thiamine Mononitrate (Vitamin B1) 5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4702
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 50 mg, Carbonyl Iron 60 mg, Copper Sulphate 0.5 mg, Cyanocobalamin 7.5 mcg, Folic Acid 0.75 mg, Pyridoxine Hcl 1.5 mg, Selenium Dioxide 75 mcg, Vitamin E Acetate 12.5 IU, Zinc Sulphate 15 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4703
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 50 mg, Cyanocobalamin 15 mcg, Ferrous Fumarate 100 mg, Folic Acid 1.5 mg, Zinc 50 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4704
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 50 mg, Elemental Iron 30 mg, Folic Acid 250 mcg (SR)

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4706
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 75 mg, Carbonyl Iron 100 mg, Folic Acid 1500 mcg, Vitamin B12 15 mcg, Zinc Sulphate Monohydrate 22.05 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4707
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 75 mg, Cyanocobalamin 10 mcg, Ferrous Fumarate 300 mg, Folic Acid 1.5 mg, Glycine 50 mg, Zinc Sulphate 80 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4708
Dosage formHard-gelatin capsules
Oral

Ascorbic Acid 75 mg, Cyanocobalamin 15 mcg, Ferrous Fumarate 300 mg, Folic Acid 1.5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product